Christopher R. Mcevoy

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Validation of the SOPHiA DDM HRD Solution as a Companion Diagnostic for Poly (ADP-Ribose) Polymerase Inhibitor Access in Australia.

Validation of the SOPHiA DDM HRD Solution as a Companion Diagnostic for Poly (ADP-Ribose) Polymerase Inhibitor Access in Australia.

Journal: The Journal of molecular diagnostics : JMD

Published: September 05, 2025

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Journal: Molecular diagnosis & therapy

Published: July 28, 2025

The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspective.

The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspective.

Journal: Pathology

Published: August 14, 2024

A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.

A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.

Journal: Cancers

Published: July 27, 2023

ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature.

ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature.

Journal: Virchows Archiv : an international journal of pathology

Published: August 05, 2022

A NUT carcinoma lacking squamous differentiation and expressing TTF1.

A NUT carcinoma lacking squamous differentiation and expressing TTF1.

Journal: Pathology

Published: July 31, 2020

A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.

A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: June 15, 2020

Improved next-generation sequencing pre-capture library yields and sequencing parameters using on-bead PCR.

Improved next-generation sequencing pre-capture library yields and sequencing parameters using on-bead PCR.

Journal: BioTechniques

Published: December 12, 2019

Emerging entities in NUTM1-rearranged neoplasms.

Emerging entities in NUTM1-rearranged neoplasms.

Journal: Genes, chromosomes & cancer

Published: December 08, 2019

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.

Journal: The Journal of clinical investigation

Published: March 06, 2019

Development and interlaboratory evaluation of a NIST Reference Material RM 8366 for EGFR and MET gene copy number measurements.

Development and interlaboratory evaluation of a NIST Reference Material RM 8366 for EGFR and MET gene copy number measurements.

Journal: Clinical chemistry and laboratory medicine

Published: December 07, 2018

Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.

Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.

Journal: The journal of pathology. Clinical research

Published: July 10, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026